BMC Musculoskeletal Disorders

Table 4 Agreement of response according to various criteria sets at 3 months, expressed as percentages and κ values

From: Disease activity level, remission and response in established rheumatoid arthritis: Performance of various criteria sets in an observational cohort, treated with anti-TNF agents

Reference criterion
		EULAR		EULAR modified cut off		SDAI		CDAI
Valid N		1163		1163		1184		1195
	Valid N	%	κ	%	κ	%	κ	%	κ
*Overall response*		*good+moderate*		*good+moderate*		*major+minor*		*major+minor*
ACR20	1234	61/22	0,61	59/24	0,62	62/19	0,54	61/19	0,54
EULAR	1163			71/23	0,83	73/17	0,71	72/17	0,68
EULAR modified cut off	1163					70/18	0,70	69/18	0,67
SDAI	1184							78/19	0,91
*Moderate/minor response*		*moderate*		*moderate*		*minor*		*minor*
ACR50	1234	13/33	0,00	3.5/47	0,00	7.3/41	0,00	5.6/45	0,00
EULAR	1163			14/54	0,27	13/43	0,04	10/46	0,03
EULAR modified cut off	1163					11/65	0,31	8.7/68	0,28
SDAI	1184							20/70	0,74
*Good/major response*		*good*		*good*		*major*		*major*
ACR70	1234	12/64	0,40	13/46	0,22	12/46	0,19	12/42	0,17
EULAR	1163			31/43	0,49	25/38	0,27	26/36	0,27
EULAR modified cut off	1163					45/39	0,69	47/37	0,69
SDAI	1184							51/42	0,86

Percentages denote positive agreement/negative agreement, i.e. per cent patients fulfilling both compared response criteria/per cent patients fulfilling neither.

Back to article page

ISSN: 1471-2474

Contact us

Submission enquiries: bmcmusculoskeletaldisorders@biomedcentral.com
General enquiries: ORSupport@springernature.com